Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.

Elshami, Mohamedraed; Goldstone, Robert N; Blaszkowsky, Lawrence S; Cusack, James C; Hong, Theodore S; Wo, Jennifer Y; Qadan, Motaz

Elshami, Mohamedraed; Goldstone, Robert N; Blaszkowsky, Lawrence S; Cusack, James C; Hong, Theodore S; Wo, Jennifer Y; Qadan, Motaz.

Afiliación

Elshami M; Harvard Medical School, Boston, Massachusetts.
Goldstone RN; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Blaszkowsky LS; Harvard Medical School, Boston, Massachusetts.
Cusack JC; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Hong TS; Newton Wellesley Hospital, Newton, Massachusetts.
Wo JY; Harvard Medical School, Boston, Massachusetts.
Qadan M; Newton Wellesley Hospital, Newton, Massachusetts.

Dis Colon Rectum ; 65(10): 1224-1231, 2022 10 01.

Article en En | MEDLINE | ID: mdl-35714358

Asunto(s)

Adenocarcinoma; Neoplasias del Recto; Adenocarcinoma/patología; Quimioradioterapia; Humanos; Masculino; Terapia Neoadyuvante; Estadificación de Neoplasias; Neoplasias del Recto/cirugía; Estudios Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Adenocarcinoma Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans / Male Idioma: En Revista: Dis Colon Rectum Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google